MRVI Stock Summary and Trading Ideas (Maravai Lifesciences Holdings - Class A | NASDAQ:MRVI)

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Maravai Lifesciences Holdings - Class A trades on the NASDAQ stock market under the symbol MRVI.

As of March 10, 2026, MRVI stock price declined to $3.50 with 1,802,847 million shares trading.

MRVI has a beta of 1.71, meaning it tends to be more sensitive to market movements. MRVI has a correlation of 0.19 to the broad based SPY ETF.

MRVI has a market cap of $507.58 million. This is considered a Small Cap stock.

Last quarter Maravai Lifesciences Holdings - Class A reported $50 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $721,514 and exceeded earnings estimates by $.04.

In the last 3 years, MRVI traded as high as $16.62 and as low as $1.67.

The top ETF exchange traded funds that MRVI belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.

MRVI has underperformed the market in the last year with a return of +18.2%, while the SPY ETF gained +18.8%. In the last 3 month period, MRVI fell short of the market, returning -5.1%, while SPY returned -0.6%. However, in the most recent 2 weeks MRVI has outperformed the stock market by returning +14.4%, while SPY returned -0.8%.

MRVI support price is $3.50 and resistance is $3.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRVI shares will trade within this expected range on the day.